None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) All patients aged 18 years of age or older with reduced LV systolic function (LVEF=40%) are targeted 2) Patients who are taking Sacubitril/valsartan or who are taking conventional ACEi/ARB oral medications and have been replaced with Sacubitril/valsartan.
Exclusion criteria
Exclusion criteria: 1) Severe shock or hypotension at registration 2) Those who have a history of angioedema 3) Those who have hypersensitivity reactions and side effects to ACE inhibitors, ARB, and NEP inhibitors 4) Patients who are pregnant or may become pregnant 5) Patients with cancer history within 5 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of change of left ventricular end systolic volume on echocardiography | — |
Secondary
| Measure | Time frame |
|---|---|
| Composite endpoints of death, non-fatal myocardial infarction, and hospitalization for stroke and heart failure;Cardiovascular death;Myocardial infarction;Stroke;Hospitalization for heart failure;Visit ER for symptoms of heart failure;Revascularization for ischemia;Echocardiographic parameter;Microalbuminuria;NT-pro BNP;BMI, Body weight | — |
Countries
Korea, Republic of
Contacts
Soon Chun Hyang University Hospital Bucheon